{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:27:45Z","timestamp":1791919665647,"version":"4.3.4"},"reference-count":57,"publisher":"XMLink","issue":"2","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100003625","name":"Ministry of Health, Welfare and Family Affairs","doi-asserted-by":"publisher","award":["A085139"],"award-info":[{"award-number":["A085139"]}],"id":[{"id":"10.13039\/501100003625","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["synapse.koreamed.org"],"crossmark-restriction":false},"short-container-title":["Clin Exp Vaccine Res"],"published-print":{"date-parts":[[2014]]},"DOI":"10.7774\/cevr.2014.3.2.168","type":"journal-article","created":{"date-parts":[[2014,6,27]],"date-time":"2014-06-27T04:54:16Z","timestamp":1403844856000},"page":"168","update-policy":"https:\/\/doi.org\/10.7774\/crossmark_policy","source":"Crossref","is-referenced-by-count":36,"title":["Current status of human papillomavirus vaccines"],"prefix":"10.7774","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9765-3443","authenticated-orcid":false,"given":"Kwang Sung","family":"Kim","sequence":"first","affiliation":[{"name":"Eyegene Inc., Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8195-142X","authenticated-orcid":false,"given":"Shin Ae","family":"Park","sequence":"additional","affiliation":[{"name":"Eyegene Inc., Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0391-7936","authenticated-orcid":false,"given":"Kyung-Nam","family":"Ko","sequence":"additional","affiliation":[{"name":"Eyegene Inc., Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seokjae","family":"Yi","sequence":"additional","affiliation":[{"name":"Eyegene Inc., Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6914-9343","authenticated-orcid":false,"given":"Yang Je","family":"Cho","sequence":"additional","affiliation":[{"name":"Eyegene Inc., Seoul, Korea."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"18617","reference":[{"key":"10.7774\/cevr.2014.3.2.168_ref1","volume-title":"GLOBOCAN 2002: cancer incidence, mortality and prevalence worldwide","author":"Ferlay","year":"2004"},{"key":"10.7774\/cevr.2014.3.2.168_ref2","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-66800-5_1","volume-title":"Human papillomaviruses and their possible role in squamous cell carcinomas","author":"Zur Hausen","year":"1977"},{"key":"10.7774\/cevr.2014.3.2.168_ref3","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1016\/j.vaccine.2005.01.016","volume":"23","author":"Franco","year":"2005","journal-title":"Vaccine"},{"key":"10.7774\/cevr.2014.3.2.168_ref4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/(SICI)1096-9896(199909)189:1<12::AID-PATH431>3.0.CO;2-F","volume":"189","author":"Walboomers","year":"1999","journal-title":"J Pathol"},{"key":"10.7774\/cevr.2014.3.2.168_ref5","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.virol.2004.03.033","volume":"324","author":"de Villiers","year":"2004","journal-title":"Virology"},{"key":"10.7774\/cevr.2014.3.2.168_ref6","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1056\/NEJMoa021641","volume":"348","author":"Munoz","year":"2003","journal-title":"N Engl J Med"},{"key":"10.7774\/cevr.2014.3.2.168_ref7","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1136\/jcp.55.4.244","volume":"55","author":"Bosch","year":"2002","journal-title":"J Clin Pathol"},{"key":"10.7774\/cevr.2014.3.2.168_ref8","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1002\/ijc.20244","volume":"111","author":"Munoz","year":"2004","journal-title":"Int J Cancer"},{"key":"10.7774\/cevr.2014.3.2.168_ref9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/0042-6822(91)90772-4","volume":"185","author":"Zhou","year":"1991","journal-title":"Virology"},{"key":"10.7774\/cevr.2014.3.2.168_ref10","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/S0006-3495(91)82181-6","volume":"60","author":"Baker","year":"1991","journal-title":"Biophys J"},{"issue":"Suppl 10","key":"10.7774\/cevr.2014.3.2.168_ref11","doi-asserted-by":"crossref","first-page":"K53","DOI":"10.1016\/j.vaccine.2008.06.002","volume":"26","author":"Schiller","year":"2008","journal-title":"Vaccine"},{"key":"10.7774\/cevr.2014.3.2.168_ref12","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S1470-2045(05)70101-7","volume":"6","author":"Villa","year":"2005","journal-title":"Lancet Oncol"},{"key":"10.7774\/cevr.2014.3.2.168_ref13","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.1016\/S0140-6736(07)60946-5","volume":"369","author":"Paavonen","year":"2007","journal-title":"Lancet"},{"key":"10.7774\/cevr.2014.3.2.168_ref14","doi-asserted-by":"crossref","first-page":"e61825","DOI":"10.1371\/journal.pone.0061825","volume":"8","author":"Draper","year":"2013","journal-title":"PLoS One"},{"key":"10.7774\/cevr.2014.3.2.168_ref15","first-page":"13","volume":"15","author":"Kols","year":"2000","journal-title":"AIDS Info Netw"},{"key":"10.7774\/cevr.2014.3.2.168_ref16","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/nbt0710-671","volume":"28","author":"Padmanabhan","year":"2010","journal-title":"Nat Biotechnol"},{"key":"10.7774\/cevr.2014.3.2.168_ref17","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1517\/13543776.2011.551114","volume":"21","author":"Cho","year":"2011","journal-title":"Expert Opin Ther Pat"},{"key":"10.7774\/cevr.2014.3.2.168_ref18","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1093\/jnci\/djj144","volume":"98","author":"McNeil","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.7774\/cevr.2014.3.2.168_ref19","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/sj.clpt.6100055","volume":"81","author":"Shi","year":"2007","journal-title":"Clin Pharmacol Ther"},{"key":"10.7774\/cevr.2014.3.2.168_ref20","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1016\/0264-410X(95)00103-8","volume":"13","author":"Jansen","year":"1995","journal-title":"Vaccine"},{"key":"10.7774\/cevr.2014.3.2.168_ref21","unstructured":"HPV vaccine formulations comprising aluminum adjuvant and methods of producing same [Internet]. Geneva. World Intellectual Property Organization. c2012. cited 2014 Feb 17. Available from: http:\/\/patentscope.wipo.int\/search\/en\/WO2012177970"},{"key":"10.7774\/cevr.2014.3.2.168_ref22","doi-asserted-by":"crossref","first-page":"pii 1000107","DOI":"10.4172\/2157-7560.1000107","volume":"1","author":"Harper","year":"2010","journal-title":"J Vaccines Vaccin"},{"key":"10.7774\/cevr.2014.3.2.168_ref23","unstructured":"US Food and Drug Administaration. Vaccines and Related Biological Products Advisory Committee (VRBPAC). VRBPAC background document: Gardasil\u2122 HPV quadrivalent vaccine [Internet]. Silverspring. FDA. c2006. cited 2014 Feb 17. Available from: http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/06\/briefing\/2006-4222B3.pdf"},{"key":"10.7774\/cevr.2014.3.2.168_ref24","unstructured":"Merck & Co. Inc. Gardasil\u00ae: quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine [Internet]. Whitehouse Station. Merck & Co. Inc. c2013. cited 2014 Feb 17. Available from: http:\/\/www.merck.ca\/assets\/en\/pdf\/products\/GARDASIL-PM_E.pdf"},{"key":"10.7774\/cevr.2014.3.2.168_ref25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.jadohealth.2011.07.003","volume":"49","author":"Haupt","year":"2011","journal-title":"J Adolesc Health"},{"key":"10.7774\/cevr.2014.3.2.168_ref26","unstructured":"Merck & Co. Inc. Form 10-K annual report [Internet]. Whitehouse Station. Merck & Co. Inc. c2014. cited 2014 Feb 17. Available from: http:\/\/www.merck.com\/investors\/financials\/annual-reports\/home.html."},{"key":"10.7774\/cevr.2014.3.2.168_ref27","unstructured":"Vaccine against HPV [Internet]. Geneva. World Intellectual Property Organization. c2010. cited 2014 Feb 17. Available from: http:\/\/patentscope.wipo.int\/search\/en\/WO2010012780"},{"key":"10.7774\/cevr.2014.3.2.168_ref28","first-page":"97","volume":"2","author":"Monie","year":"2008","journal-title":"Biologics"},{"key":"10.7774\/cevr.2014.3.2.168_ref29","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1016\/S0140-6736(04)17398-4","volume":"364","author":"Harper","year":"2004","journal-title":"Lancet"},{"key":"10.7774\/cevr.2014.3.2.168_ref30","first-page":"465","volume":"71","author":"McKeage","year":"2011","journal-title":"Drugs"},{"key":"10.7774\/cevr.2014.3.2.168_ref31","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1586\/14760584.6.5.723","volume":"6","author":"Garcon","year":"2007","journal-title":"Expert Rev Vaccines"},{"key":"10.7774\/cevr.2014.3.2.168_ref32","doi-asserted-by":"crossref","first-page":"926","DOI":"10.4049\/jimmunol.168.2.926","volume":"168","author":"Ismaili","year":"2002","journal-title":"J Immunol"},{"key":"10.7774\/cevr.2014.3.2.168_ref33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.2165\/00003495-200868030-00007","volume":"68","author":"Keam","year":"2008","journal-title":"Drugs"},{"key":"10.7774\/cevr.2014.3.2.168_ref34","unstructured":"US Food and Drug Administaration. Cervarix: human papillomavirus bivalent (types 16 and 18) vaccine, recombinant. Vaccines and Related Biological Products Advisory Committee (VRBPAC) briefing document [Internet]. Silverspring. FDA. c2009. cited 2014 Feb 17. Available from: http:\/\/www.fda.gov\/downloads\/AdvisoryCommittees\/CommitteesMeetingMaterials\/BloodVaccinesandOtherBiologics\/VaccinesandRelatedBiologicalProductsAdvisoryCommittee\/UCM181371.pdf"},{"key":"10.7774\/cevr.2014.3.2.168_ref35","unstructured":"US Food and Drug Administaration. Clinical review of biologics license application for human papillomavirus 16, 18 L1 virus like particle vaccine, AS04 adjuvant-adsorbed (Cervarix) [Internet]. Silverspring. FDA. c2009. cited 2014 Feb 17. Available from: http:\/\/www.fda.gov\/downloads\/biologicsbloodvaccines\/vaccines\/approvedproducts\/ucm237976.pdf"},{"key":"10.7774\/cevr.2014.3.2.168_ref36","doi-asserted-by":"crossref","first-page":"390","DOI":"10.4161\/hv.18865","volume":"8","author":"Roteli-Martins","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.7774\/cevr.2014.3.2.168_ref37","doi-asserted-by":"crossref","first-page":"457204","DOI":"10.5402\/2011\/457204","volume":"2011","author":"Harper","year":"2011","journal-title":"ISRN Obstet Gynecol"},{"key":"10.7774\/cevr.2014.3.2.168_ref38","unstructured":"GlaxoSmithKline plc. Form 20-F: GSK annual report 2012 [Internet]. Brentford. GlaxoSmithKline plc. c2013. cited 2014 Feb 17. Available from: http:\/\/www.gsk.com\/content\/dam\/gsk\/globals\/documents\/pdf\/GSK-form-20-F-2012.pdf"},{"key":"10.7774\/cevr.2014.3.2.168_ref39","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4161\/hv.7.12.18281","volume":"7","author":"Einstein","year":"2011","journal-title":"Hum Vaccin"},{"key":"10.7774\/cevr.2014.3.2.168_ref40","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/ni1112","volume":"5","author":"Iwasaki","year":"2004","journal-title":"Nat Immunol"},{"key":"10.7774\/cevr.2014.3.2.168_ref41","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1016\/j.vaccine.2013.05.046","volume":"31","author":"Zhang","year":"2013","journal-title":"Vaccine"},{"key":"10.7774\/cevr.2014.3.2.168_ref42","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1016\/j.vaccine.2013.04.082","volume":"31","author":"Pagliusi","year":"2013","journal-title":"Vaccine"},{"key":"10.7774\/cevr.2014.3.2.168_ref43","unstructured":"Takeda. Annual report 2011 [Internet]. Osaka. Takeda. c2011. cited 2014 Feb 17. Available from: http:\/\/www.takeda.com\/csr\/reports\/pdf\/index\/ar2011_en.pdf"},{"key":"10.7774\/cevr.2014.3.2.168_ref44","unstructured":"Takeda. Annual report 2013 [Internet]. Osaka. Takeda. c2013. cited 2014 Feb 17. Available from: http:\/\/www.takeda.com\/investor-information\/annual\/files\/ar2013_en.pdf"},{"key":"10.7774\/cevr.2014.3.2.168_ref45","doi-asserted-by":"crossref","first-page":"4127","DOI":"10.1016\/j.vaccine.2012.04.079","volume":"30","author":"Han","year":"2012","journal-title":"Vaccine"},{"key":"10.7774\/cevr.2014.3.2.168_ref46","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1586\/14760584.2013.811185","volume":"12","author":"Mount","year":"2013","journal-title":"Expert Rev Vaccines"},{"key":"10.7774\/cevr.2014.3.2.168_ref47","doi-asserted-by":"crossref","first-page":"e85838","DOI":"10.1371\/journal.pone.0085838","volume":"9","author":"Han","year":"2014","journal-title":"PLoS One"},{"key":"10.7774\/cevr.2014.3.2.168_ref48","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1001\/jama.2009.1201","volume":"302","author":"Slade","year":"2009","journal-title":"JAMA"},{"key":"10.7774\/cevr.2014.3.2.168_ref49","unstructured":"US Food and Drug Administration. Gardasil vaccine safety [Internet]. Silverspring. FDA. c2009. cited 2014 Feb 17. Available from: http:\/\/www.fda.gov\/BiologicsBloodVaccines\/SafetyAvailability\/VaccineSafety\/ucm179549.htm"},{"key":"10.7774\/cevr.2014.3.2.168_ref50","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3233\/JRS-2011-0529","volume":"23","author":"Labadie","year":"2011","journal-title":"Int J Risk Saf Med"},{"key":"10.7774\/cevr.2014.3.2.168_ref51","volume-title":"HPV update: what nurse practitioners need to know practical strategies for helping patients and parents understand the importance of HPV vaccination","author":"Rubin","year":"2011"},{"key":"10.7774\/cevr.2014.3.2.168_ref52","unstructured":"Progress in preventing cervical cancer: updated evidence on vaccination and screening [Internet]. Seattle. Program for Appropriate Technology in Health (PATH). c2010. cited 2014 Feb 17. Available from: http:\/\/www.path.org\/publications\/files\/RH_outlook_27_2.pdf"},{"key":"10.7774\/cevr.2014.3.2.168_ref53","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/jnci\/djr053","volume":"103","author":"Peres","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.7774\/cevr.2014.3.2.168_ref54","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1007\/s00705-009-0484-8","volume":"154","author":"Bazan","year":"2009","journal-title":"Arch Virol"},{"key":"10.7774\/cevr.2014.3.2.168_ref55","doi-asserted-by":"crossref","first-page":"339","DOI":"10.4161\/hv.7.3.14263","volume":"7","author":"Rybicki","year":"2011","journal-title":"Hum Vaccin"},{"issue":"Suppl 5","key":"10.7774\/cevr.2014.3.2.168_ref56","doi-asserted-by":"crossref","first-page":"F139","DOI":"10.1016\/j.vaccine.2012.05.039","volume":"30","author":"Markowitz","year":"2012","journal-title":"Vaccine"},{"key":"10.7774\/cevr.2014.3.2.168_ref57","first-page":"1705","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"}],"container-title":["Clinical and Experimental Vaccine Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/synapse.koreamed.org\/DOIx.php?id=10.7774\/cevr.2014.3.2.168","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/synapse.koreamed.org\/pdf\/10.7774\/cevr.2014.3.2.168","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ecevr.org\/DOIx.php?id=10.7774\/cevr.2014.3.2.168","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,21]],"date-time":"2020-08-21T11:51:45Z","timestamp":1598010705000},"score":1,"resource":{"primary":{"URL":"https:\/\/ecevr.org\/DOIx.php?id=10.7774\/cevr.2014.3.2.168"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":57,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.7774\/cevr.2014.3.2.168","relation":{},"ISSN":["2287-3651","2287-366X"],"issn-type":[{"value":"2287-3651","type":"print"},{"value":"2287-366X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]},"assertion":[{"value":"https:\/\/synapse.koreamed.orgDOIx.php?id=10.7774\/cevr.2014.3.2.168","URL":"https:\/\/synapse.koreamed.orgDOIx.php?id=10.7774\/cevr.2014.3.2.168","name":"synapse","label":"Synapse","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"http:\/\/ecevr.org\/DOIx.php?id=10.7774\/cevr.2014.3.2.168","URL":"http:\/\/ecevr.org\/DOIx.php?id=10.7774\/cevr.2014.3.2.168","name":"the_journal","label":"the Journal","group":{"name":"multiple_resolution","label":"Full text available at:"}},{"value":"http:\/\/orcid.org\/0000-0001-9765-3443","URL":"http:\/\/orcid.org\/0000-0001-9765-3443","name":"author","label":"Kwang Sung Kim","group":{"name":"orcid","label":"ORCID"}},{"value":"http:\/\/orcid.org\/0000-0001-8195-142X","URL":"http:\/\/orcid.org\/0000-0001-8195-142X","name":"author","label":"Shin Ae Park","group":{"name":"orcid","label":"ORCID"}},{"value":"http:\/\/orcid.org\/0000-0002-0391-7936","URL":"http:\/\/orcid.org\/0000-0002-0391-7936","name":"author","label":"Kyung-Nam Ko","group":{"name":"orcid","label":"ORCID"}},{"value":"http:\/\/orcid.org\/0000-0002-6914-9343","URL":"http:\/\/orcid.org\/0000-0002-6914-9343","name":"author","label":"Yang Je Cho","group":{"name":"orcid","label":"ORCID"}},{"value":"2014-04-15","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-16","name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-05-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2014-06-20","name":"published_online","label":"Published online","group":{"name":"publication_history","label":"Publication History"}},{"value":"\u00a9 Korean Vaccine Society.","name":"copyright","label":"Copyright","group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}},{"value":"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.","name":"license","label":"License","explanation":{"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"},"group":{"name":"Copyright_and_licensing","label":"Copyright and Licensing"}}]}}